03 September 2010
Keywords: Bristol-Myers Squibb, Plaxiv, Sanofi-Aventis, blood thinner
Article | 20 August 2009
US drug major Bristol-Myers Squibb says that its lead drug, Plavix (clopidogrel), the blood thinner co-marketed under an agreement with its originator, French giant Sanofi-Aventis, will be reviewed by the US Patent and Trademark Office (PTO).
S Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscriptions are £60 per month, pay as you go.
Find out more details.